Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10769254 | Biochemical and Biophysical Research Communications | 2005 | 8 Pages |
Abstract
Glucocorticoids are widely prescribed anti-inflammatory drugs used for the treatment of many inflammatory lung disorders. However, much still remains unknown about their molecular mechanisms of action. We have previously shown that glucocorticoid-induced transcription in the lung epithelial cell line NCI-H441 is mediated via C/EBP sites in the promoters of target genes, and is likely to involve the transcription factors C/EBPβ and C/EBPδ. Here, we report that C/EBPβ is the most active C/EBP-factor in both human and mouse lung epithelium and that glucocorticoids induce DNA binding of C/EBPβ in cultured primary mouse lung epithelial cells. Mechanistic studies in H441 cells revealed that glucocorticoids, acting via the glucocorticoid receptor, increase C/EBPβ binding starting 10 min after stimulation. The mechanism is independent of de novo protein synthesis and involves phosphorylation of C/EBPβ at Thr235. Together this shows that glucocorticoids increase DNA-binding activity of C/EBPβ via post-translational mechanism(s) involving phosphorylation.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Tove Berg, Lukas Didon, Jenny Barton, Olof Andersson, Magnus Nord,